Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

297 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparison of gene expression profile of epiretinal membranes obtained from eyes with proliferative vitreoretinopathy to that of secondary epiretinal membranes.
Asato R, Yoshida S, Ogura A, Nakama T, Ishikawa K, Nakao S, Sassa Y, Enaida H, Oshima Y, Ikeo K, Gojobori T, Kono T, Ishibashi T. Asato R, et al. Among authors: nakama t. PLoS One. 2013;8(1):e54191. doi: 10.1371/journal.pone.0054191. Epub 2013 Jan 23. PLoS One. 2013. PMID: 23372684 Free PMC article.
Periostin promotes the generation of fibrous membranes in proliferative vitreoretinopathy.
Ishikawa K, Yoshida S, Nakao S, Nakama T, Kita T, Asato R, Sassa Y, Arita R, Miyazaki M, Enaida H, Oshima Y, Murakami N, Niiro H, Ono J, Matsuda A, Goto Y, Akashi K, Izuhara K, Kudo A, Kono T, Hafezi-Moghadam A, Ishibashi T. Ishikawa K, et al. Among authors: nakama t. FASEB J. 2014 Jan;28(1):131-42. doi: 10.1096/fj.13-229740. Epub 2013 Sep 10. FASEB J. 2014. PMID: 24022401
Overexpression of CD163 in vitreous and fibrovascular membranes of patients with proliferative diabetic retinopathy: possible involvement of periostin.
Kobayashi Y, Yoshida S, Nakama T, Zhou Y, Ishikawa K, Arita R, Nakao S, Miyazaki M, Sassa Y, Oshima Y, Izuhara K, Kono T, Ishibashi T. Kobayashi Y, et al. Among authors: nakama t. Br J Ophthalmol. 2015 Apr;99(4):451-6. doi: 10.1136/bjophthalmol-2014-305321. Epub 2014 Oct 3. Br J Ophthalmol. 2015. PMID: 25281471
Increased expression of M-CSF and IL-13 in vitreous of patients with proliferative diabetic retinopathy: implications for M2 macrophage-involving fibrovascular membrane formation.
Yoshida S, Kobayashi Y, Nakama T, Zhou Y, Ishikawa K, Arita R, Nakao S, Miyazaki M, Sassa Y, Oshima Y, Izuhara K, Kono T, Ishibashi T. Yoshida S, et al. Among authors: nakama t. Br J Ophthalmol. 2015 May;99(5):629-34. doi: 10.1136/bjophthalmol-2014-305860. Epub 2014 Oct 29. Br J Ophthalmol. 2015. PMID: 25355804
Inhibition of choroidal fibrovascular membrane formation by new class of RNA interference therapeutic agent targeting periostin.
Nakama T, Yoshida S, Ishikawa K, Kobayashi Y, Zhou Y, Nakao S, Sassa Y, Oshima Y, Takao K, Shimahara A, Yoshikawa K, Hamasaki T, Ohgi T, Hayashi H, Matsuda A, Kudo A, Nozaki M, Ogura Y, Kuroda M, Ishibashi T. Nakama T, et al. Gene Ther. 2015 Feb;22(2):127-37. doi: 10.1038/gt.2014.112. Epub 2014 Dec 11. Gene Ther. 2015. PMID: 25503692
297 results